GRAHIQA
DEAD

Serial Number

79352026

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GRAHIQA Trademark

Serial Number: 79352026 • Registration: 7178568

GRAHIQA is a trademark filed by NOVARTIS AG on September 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 2, 2022

Registration Date

October 3, 2023

Published for Opposition

July 18, 2023

Cancellation Date

October 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 8, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 8, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2024 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jan 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 13, 2023 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2023 CRFA
ASSIGNED TO LIE
Jun 5, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 6, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2022 RFCR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 7, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 7, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 7, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 7, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2022 COAR
NON-FINAL ACTION WRITTEN
Nov 7, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 20, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 6, 2022 SDRC